Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
111C-UCB-J PET-CT----1件: 8 💬
218F-FDG PET-MR1件: Fludeoxyglucose (18F)1件: Fludeoxyglucose F 18 💬 --1件: 8 💬
320 MG BID OF PF-02545920----1件: 8 💬
420MG daily citalopram----1件: 8 💬
531-phosphorus RMN spectroscopy----1件: 8 💬
65-chloro-1,2-dihydro-N-ethyl-4-hydroxy-1-methyl-2-OXO-N-phenyl-3-quinolinecarboxamide sodium----1件: 8 💬
7Aavrh10.CAG.HCYP46a1----1件: 8 💬
8AB-1001 gene therapy----1件: 8 💬
9ACR16----1件: 8 💬
10ACR16 10 MG----1件: 8 💬
11ACR16 22.5 MG----1件: 8 💬
12ACR16 45 MG----1件: 8 💬
13ACR16 hydrochloride, ASP2314 hydrochloride, FR310826----1件: 8 💬
14Adeno-associated viral vector serotype RH10 containing THE human cholesterol 24-hydroxylase gene----1件: 8 💬
15Adeno-associated virus serotype 5 encoding A microrna targeted TO human huntingtin gene----1件: 8 💬
16AFQ056----3件: 6, 8, 206 💬
17ALN-HTT02----1件: 8 💬
18Alprazolam1件: Alprazolam1件: Alprazolam 💬 16件: GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRB,
GABRB,
GABRB,
GABRD,
GABRE,
GABRG,
GABRG,
GABRG,
GABRP,
GABRQ 💬
8件: GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬2件: 8, 75 💬
19Amantadine1件: Amantadine2件: Amantadine hydrochloride ,
Amantadine 💬
5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
21件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬4件: 6, 8, 13, 127 💬
20AMT-1301件: AMT-130---1件: 8 💬
21ANTI-parkinson medication----5件: 5, 6, 7, 8, 17 💬
22ANX005----3件: 2, 8, 61 💬
23Atomoxetine1件: Atomoxetine2件: Atomoxetine hydrochloride ,
Atomoxetine 💬
1件: SLC6A2 💬 2件: Neuroactive ligand signaling, Synaptic vesicle cycle 💬3件: 6, 8, 13 💬
24Autologous stem cell----1件: 8 💬
25Benerva----1件: 8 💬
26Bevantolol hydrochloride1件: Bevantolol1件: Bevantolol hydrochloride 💬 8件: ADRA1A,
ADRA1B,
ADRA1D,
ADRB1,
CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬
44件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gap junction, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hormone signaling, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 8 💬
27Bevantololo cloridrato----1件: 8 💬
28Biostamp npoint device----1件: 8 💬
29Biotin1件: Biotin1件: Biotin 💬 --3件: 2, 8, 13 💬
30Biotina1件: Biotin1件: Biotin 💬 --1件: 8 💬
31Blood sample----28件: 2, 3, 8, 13, 34, 46, 49, 51, 53, 61, 65, 66, 67, 84, 88, 96, 97, 107, 113, 127, 195, 206, 235, 274, 280, 288, 294, 299 💬
32BN82451B----1件: 8 💬
33BN8251B----1件: 8 💬
34Body composition using A HAND-held body FAT monitor • resting metabolic rate (RMR) using A ventilated hood system----1件: 8 💬
35Brain MRI----3件: 8, 25, 229 💬
36Branaplam1件: Branaplam1件: Branaplam 💬 --2件: 3, 8 💬
37Bupropion1件: Bupropion3件: Bupropion hydrochloride ,
Bupropion ,
Bupropion hydrobromide 💬
2件: SLC6A2,
SLC6A3 💬
8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬3件: 8, 21, 96 💬
38BV-101----1件: 8 💬
39Calvan tablets 100----1件: 8 💬
40Calvan® 100 MG----1件: 8 💬
41Cannabidiol1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬
4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬18件: 6, 8, 13, 19, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 271 💬
42CBD----9件: 6, 8, 13, 36, 140, 144, 145, 156, 158 💬
43Cellavita HD higher dose----1件: 8 💬
44Cellavita HD lower dose----1件: 8 💬
45Cellavita-HD----1件: 8 💬
46CKD-5041件: CKD-504---1件: 8 💬
47Coenzyme Q101件: Ubidecarenone1件: Ubidecarenone 💬 --12件: 2, 5, 6, 8, 10, 46, 57, 107, 113, 193, 214, 215 💬
48Cognitive evaluation----1件: 8 💬
49COQ101件: Ubidecarenone1件: Ubidecarenone 💬 --4件: 5, 6, 8, 96 💬
50Creatine1件: Creatine---10件: 1, 2, 6, 8, 13, 46, 49, 50, 201, 337 💬
51Creatine monohydrate1件: Creatine---5件: 2, 8, 97, 113, 156 💬
52Cystagon1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬
--3件: 8, 19, 299 💬
53Cysteamine bitartrate1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬
--4件: 8, 19, 21, 299 💬
54Deep brain stimulation----5件: 5, 6, 7, 8, 17 💬
55Deutetrabenazine1件: Deutetrabenazine1件: Deutetrabenazine 💬 1件: SLC18A1_2 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 8 💬
56Dextromethorphan1件: Dextromethorphan3件: Dextromethorphan hydrobromide ,
Dextromethorphan ,
Daunorubicin 💬
6件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SIGMAR1 💬
21件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬8件: 6, 8, 13, 21, 85, 96, 97, 156 💬
57Digoxin1件: Digoxin1件: Digoxin 💬 4件: ATP1A,
ATP1A,
ATP1A,
ATP1A 💬
19件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cytoskeleton in muscle cells, Endocrine and other factor-regulated calcium reabsorption, Gastric acid secretion, Insulin secretion, Mineral absorption, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Thyroid hormone signaling pathway, Thyroid hormone synthesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬3件: 8, 46, 210 💬
58Dimebon1件: Latrepirdine2件: Latrepirdine ,
Latrepirdine dihydrochloride 💬
6件: ACHE,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
59Dimebon + dextromethorphan2件: Dextromethorphan,
Latrepirdine
5件: Dextromethorphan hydrobromide ,
Dextromethorphan ,
Daunorubicin ,
Latrepirdine ,
Latrepirdine dihydrochloride 💬
7件: ACHE,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SIGMAR1 💬
23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
60Dimebon + ketoconazole1件: Latrepirdine2件: Latrepirdine ,
Latrepirdine dihydrochloride 💬
6件: ACHE,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
61Dimebon + omeprazole1件: Latrepirdine2件: Latrepirdine ,
Latrepirdine dihydrochloride 💬
6件: ACHE,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
62Dimebon alone1件: Latrepirdine2件: Latrepirdine ,
Latrepirdine dihydrochloride 💬
6件: ACHE,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
63Dimebon dihydrochloride1件: Latrepirdine2件: Latrepirdine ,
Latrepirdine dihydrochloride 💬
6件: ACHE,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
64Dimebon IR1件: Latrepirdine2件: Latrepirdine ,
Latrepirdine dihydrochloride 💬
6件: ACHE,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
65Dimebon IR tablet1件: Latrepirdine2件: Latrepirdine ,
Latrepirdine dihydrochloride 💬
6件: ACHE,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
66Dimebon MR11件: Latrepirdine2件: Latrepirdine ,
Latrepirdine dihydrochloride 💬
6件: ACHE,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
67Dimebon MR21件: Latrepirdine2件: Latrepirdine ,
Latrepirdine dihydrochloride 💬
6件: ACHE,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
68Dimebon MR31件: Latrepirdine2件: Latrepirdine ,
Latrepirdine dihydrochloride 💬
6件: ACHE,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
69Dimebon MR41件: Latrepirdine2件: Latrepirdine ,
Latrepirdine dihydrochloride 💬
6件: ACHE,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
70Dimebon transdermal1件: Latrepirdine2件: Latrepirdine ,
Latrepirdine dihydrochloride 💬
6件: ACHE,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
71Divalproex----1件: 8 💬
72Egcg1件: Epigallocatechin gallate---6件: 6, 8, 13, 28, 85, 206 💬
73Epigallocatechin-3-gallate2件: Epigallocatechin,
Epigallocatechin gallate
---3件: 8, 28, 85 💬
74ER2001 injection1件: ER2001---1件: 8 💬
75Ethyl icosapent1件: Icosapent ethyl1件: Icosapent ethyl 💬 --1件: 8 💬
76Ethyl-EPA1件: Icosapent ethyl1件: Icosapent ethyl 💬 --1件: 8 💬
77Ethyl-icosapent1件: Icosapent ethyl1件: Icosapent ethyl 💬 --1件: 8 💬
78Fenofibrate1件: Fenofibrate1件: Fenofibrate 💬 1件: NR1C1 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬6件: 8, 79, 93, 94, 97, 265 💬
79Graft intracerebral OF foetal neurons----1件: 8 💬
80GSK356278----1件: 8 💬
81Haloperidol 2MG TAB1件: Haloperidol3件: Haloperidol ,
Haloperidol decanoate ,
Haloperidol lactate 💬
1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 8 💬
82High doses OF thiamine Y biotin----1件: 8 💬
83Hyperium1件: Rilmenidine1件: Rilmenidine 💬 3件: ADRA2A,
ADRA2B,
ADRA2C 💬
4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 8 💬
84Idebenone1件: Idebenone1件: Idebenone 💬 --7件: 6, 8, 13, 18, 21, 113, 302 💬
85Imitation (sham) surgery----1件: 8 💬
86Intra-striatal RAAV5-mihtt----1件: 8 💬
87Intraparenchymal RAAV1 - (MI)RNA HTT----1件: 8 💬
88Isis 443139 10 MG----1件: 8 💬
89Isis 443139 120 MG----1件: 8 💬
90Isis 443139 30 MG----1件: 8 💬
91Isis 443139 60 MG----1件: 8 💬
92Isis 443139 90 MG----1件: 8 💬
93Laquinimod1件: Laquinimod1件: Laquinimod sodium 💬 --4件: 8, 13, 49, 96 💬
94Laquinimod capsules 0.5 MG1件: Laquinimod1件: Laquinimod sodium 💬 --2件: 8, 96 💬
95Latrepirdine1件: Latrepirdine2件: Latrepirdine ,
Latrepirdine dihydrochloride 💬
6件: ACHE,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
96LAX-1011件: LAX-101---1件: 8 💬
97Lithium----5件: 2, 5, 6, 7, 8 💬
98LMI070----2件: 3, 8 💬
99LPM3770164 sustained release tablet----1件: 8 💬
100LPM3770164 sustained release tablet simulant----1件: 8 💬
101Lumbar punction----1件: 8 💬
102MBF-015 16 MG oral capsules----1件: 8 💬
103Melatonin1件: Melatonin1件: Melatonin 💬 2件: MTNR1A,
MTNR1B 💬
2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬16件: 2, 6, 8, 13, 37, 46, 49, 72, 78, 86, 90, 96, 97, 145, 149, 202 💬
104Memantine1件: Memantine2件: Memantine hydrochloride ,
Memantine 💬
5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
21件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬8件: 2, 6, 8, 13, 49, 127, 205, 206 💬
105Metformin1件: Metformin2件: Metformin hydrochloride ,
Metformin 💬
2件: PRKAA,
PRKAA 💬
20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬23件: 2, 6, 8, 13, 46, 49, 60, 65, 66, 67, 75, 77, 84, 86, 97, 113, 127, 206, 218, 225, 265, 285, 298 💬
106Minocycline1件: Minocycline2件: Minocycline hydrochloride ,
Minocycline 💬
--14件: 2, 6, 8, 13, 46, 85, 90, 94, 97, 162, 201, 206, 280, 299 💬
107Moderate doses OF thiamine Y biotin----1件: 8 💬
108Mutation IN THE gene----1件: 8 💬
109NAC----6件: 8, 34, 51, 85, 90, 299 💬
110Neflamapimod1件: Neflamapimod1件: Neflamapimod 💬 4件: P38,
P38,
P38,
P38 💬
62件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Alcoholic liver disease, Amyotrophic lateral sclerosis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Dopaminergic synapse, Efferocytosis, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hepatitis B, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, IL-17 signaling pathway, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Oocyte meiosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Relaxin signaling pathway, Retrograde endocannabinoid signaling, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Yersinia infection 💬1件: 8 💬
111Nicotinamide riboside3件: Nicotinamide,
Nicotinamide riboside,
Zinc
1件: Niacinamide 💬 --13件: 2, 5, 6, 7, 8, 17, 18, 21, 49, 60, 65, 85, 191 💬
112Nilotinib 150 MG1件: Nilotinib1件: Nilotinib 💬 4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬
32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 8 💬
113NON invasive prenatal diagnosis----3件: 8, 113, 206 💬
114Olanzapine1件: Olanzapine2件: Olanzapine ,
Olanzapine pamoate 💬
11件: ADRA1A,
ADRA1B,
ADRA1D,
DRD2,
DRD3,
DRD4,
HRH1,
HTR2,
HTR2,
HTR2,
HTR6 💬
18件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Salivary secretion, Serotonergic synapse, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 2, 8 💬
115OMS643762----1件: 8 💬
116OSU6162 similar TO (-)-OSU 6162----2件: 6, 8 💬
117PBF-999----1件: 8 💬
118PBF-999 / 160 MG----1件: 8 💬
119PBF-999 / 320 MG----1件: 8 💬
120PBT2----1件: 8 💬
121PF-02545920----1件: 8 💬
122PL101----1件: 8 💬
123Pridiopidine----1件: 8 💬
124Pridopidina----1件: 8 💬
125Pridopidine1件: Pridopidine2件: Pridopidine ,
Pridopidine hydrochloride 💬
1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬3件: 2, 6, 8 💬
126Pridopidine hydrochloride1件: Pridopidine2件: Pridopidine ,
Pridopidine hydrochloride 💬
1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 8 💬
127PS659----1件: 8 💬
128PTC518----1件: 8 💬
129PTC518 tablet 20 MG----1件: 8 💬
130PTC518 tablet 5 MG----1件: 8 💬
131Quinidine1件: Quinidine4件: Quinidine gluconate ,
Quinidine polygalacturonate ,
Quinidine sulfate ,
Quinidine 💬
5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 8 💬
132RAAV5-mihtt1件: AMT-130---1件: 8 💬
133Ramelteon1件: Ramelteon1件: Ramelteon 💬 2件: MTNR1A,
MTNR1B 💬
2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬3件: 6, 8, 46 💬
134Resveratrol1件: Resveratrol---5件: 8, 18, 89, 113, 299 💬
135RG6042, formerly isis 443139, ionis-httrx----1件: 8 💬
136Rilmenidine1件: Rilmenidine1件: Rilmenidine 💬 3件: ADRA2A,
ADRA2B,
ADRA2C 💬
4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 8 💬
137Riluzole1件: Riluzole1件: Riluzole 💬 14件: GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
24件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬8件: 2, 3, 5, 8, 13, 17, 203, 206 💬
138Risperidone1件: Risperidone1件: Risperidone 💬 2件: DRD2,
HTR2 💬
13件: Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 💬3件: 8, 156, 187 💬
139Risperidone 1MG TAB1件: Risperidone1件: Risperidone 💬 2件: DRD2,
HTR2 💬
13件: Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 💬1件: 8 💬
140RO 723-4292/F02----1件: 8 💬
141RO7234292----1件: 8 💬
142Rolipram1件: Rolipram1件: Rolipram 💬 4件: PDE4,
PDE4,
PDE4,
PDE4 💬
4件: Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬2件: 8, 13 💬
143RP 103----2件: 8, 19 💬
144RP103----2件: 8, 19 💬
145SAGE-718----2件: 6, 8 💬
146SBT-020----1件: 8 💬
147SD-809----1件: 8 💬
148Selisistat1件: Selisistat---1件: 8 💬
149SEN0014196----1件: 8 💬
150SKY-0515----1件: 8 💬
151Sodium phenylbutyrate1件: Phenylbutyric acid1件: Sodium phenylbutyrate 💬 --4件: 2, 3, 8, 251 💬
152SOM3355----1件: 8 💬
153SOM3355 100MG BID----1件: 8 💬
154SOM3355 200MG BID----1件: 8 💬
155SOM3355 capsules----1件: 8 💬
156SPK-10001----1件: 8 💬
157SRX246----1件: 8 💬
158SS-20----1件: 8 💬
159Tetrabenazine1件: Tetrabenazine1件: Tetrabenazine 💬 1件: SLC18A1_2 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 8 💬
160Tetrabenazine withdrawal1件: Tetrabenazine1件: Tetrabenazine 💬 1件: SLC18A1_2 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 8 💬
161Tetrahydrocannabinol1件: Dronabinol1件: Dronabinol 💬 2件: CNR1,
CNR2 💬
4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬3件: 8, 13, 298 💬
162THC----3件: 8, 13, 36 💬
163Tiapridal----1件: 8 💬
164Tominersen1件: Tominersen1件: Tominersen 💬 1件: HD 💬 2件: Huntington disease, Pathways of neurodegeneration - multiple diseases 💬1件: 8 💬
165Tominersen 100 MG1件: Tominersen1件: Tominersen 💬 1件: HD 💬 2件: Huntington disease, Pathways of neurodegeneration - multiple diseases 💬1件: 8 💬
166Tominersen 60 MG1件: Tominersen1件: Tominersen 💬 1件: HD 💬 2件: Huntington disease, Pathways of neurodegeneration - multiple diseases 💬1件: 8 💬
167Triheptanoin1件: Triheptanoin1件: Triheptanoin 💬 --10件: 2, 8, 65, 149, 156, 248, 256, 257, 317, 324 💬
168Triheptanoin 1G/KG/DAY1件: Triheptanoin1件: Triheptanoin 💬 --1件: 8 💬
169Triheptanoin OIL1件: Triheptanoin1件: Triheptanoin 💬 --1件: 8 💬
170TV-5600----3件: 8, 13, 96 💬
171TV-7820----1件: 8 💬
172Ubiquinol1件: Ubiquinol---3件: 6, 8, 17 💬
173Ursodiol1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬6件: 8, 20, 93, 97, 234, 299 💬
174UX007----5件: 8, 248, 256, 257, 344 💬
175Valbenazine1件: Valbenazine2件: Valbenazine ,
Valbenazine tosylate 💬
1件: SLC18A1_2 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 8 💬
176Vitamin B71件: Biotin1件: Biotin 💬 --1件: 8 💬
177VO6591件: VO659---1件: 8 💬
178VX-745----1件: 8 💬
179VX15/2503----2件: 8, 13 💬
180Warfarin1件: Warfarin3件: Warfarin sodium ,
Warfarin potassium ,
Warfarin 💬
2件: NQO1,
VKORC1 💬
5件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬10件: 6, 8, 19, 46, 49, 66, 85, 86, 88, 91 💬
181WVE-0031件: WVE-003---1件: 8 💬
182WVE-120101----1件: 8 💬
183WVE-120102----1件: 8 💬
184Xenazine----1件: 8 💬
185Zoloft 50MG tablet----1件: 8 💬